ADAM OMELIANCHUK to Tissue and Organ Procurement
This is a "connection" page, showing publications ADAM OMELIANCHUK has written about Tissue and Organ Procurement.
Connection Strength
4.631
-
Gerrymandering Circulation: Why NRP is Inconsistent with the Dead Donor Rule. Am J Bioeth. 2024 06; 24(6):62-66.
Score: 0.668
-
Xenograft recipients and the right to withdraw from a clinical trial. Bioethics. 2024 05; 38(4):308-315.
Score: 0.649
-
In defense of xenotransplantation research: Because of, not in spite of, animal welfare concerns. Xenotransplantation. 2023 01; 30(1):e12791.
Score: 0.605
-
Against abandoning the dead donor rule: reply to Smith. J Med Ethics. 2023 10; 49(10):715-716.
Score: 0.601
-
Can double-effect reasoning justify lethal organ donation? Bioethics. 2022 07; 36(6):648-654.
Score: 0.575
-
The inviolateness of life and equal protection: a defense of the dead-donor rule. Theor Med Bioeth. 2022 02; 43(1):1-27.
Score: 0.571
-
How (not) to think of the 'dead-donor' rule. Theor Med Bioeth. 2018 02; 39(1):1-25.
Score: 0.430
-
Ethical controversies in organ procurement: A national survey on public perceptions of thoracoabdominal normothermic regional perfusion. Am J Transplant. 2026 Apr; 26(4):785-796.
Score: 0.185
-
The promise of xenotransplantation: a challenge. J Med Ethics. 2025 Jul 23; 51(8):512-515.
Score: 0.181
-
Neither Ethical nor Prudent: Why Not to Choose Normothermic Regional Perfusion. Hastings Cent Rep. 2024 Jul; 54(4):14-23.
Score: 0.166